This activity was originally broadcast live at PTCE and Asembia Specialty Pharmacy Day of Education 2023.
Program Description
In generalized myasthenia gravis (gMG), patients experience muscle weakness and difficulty controlling voluntary muscle movements across multiple systems due to disruptions in the communication between the nerve and the muscle at the neuromuscular junction. The treatment of gMG is highly individualized based on patient presentation and response, and specialty pharmacists must be familiar with recently approved and investigational medications to modify the disease progression and quickly resolve exacerbations. Patients with gMG are initially treated with a cholinesterase inhibitor and immunosuppressive therapies, such as prednisone, as maintenance therapy. This program will explore emerging agents in the treatment of gMG and present clinical data highlighting the safety and efficacy of recently approved and investigational therapies. Specialty pharmacists are central in the management of rare diseases. Their roles in the multidisciplinary care of patients with gMG to improve clinical recommendations and assist patients in navigating the health care system will be discussed.
Target Audience: Managed Care Pharmacist, Specialty Pharmacist
Type of Activity: Application
Release date: October 17, 2023
Expiration date: October 17, 2024
Learner Level: Foundational and Intermediate
Time to complete activity: 1.0 hour
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain risk factors, pathophysiology, and the significant impact of generalized myasthenia gravis (gMG) on patient quality of life
- Examine the efficacy and safety of new and emerging therapies for gMG, as well as their mechanisms of action, dosing, and administration
- Identify the role of the pharmacist in improving outcomes for patients with gMG through patient counseling, addressing barriers to adherence, and management of adverse effects
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
